MedPath

Racemetyrosine

Generic Name
Racemetyrosine
Drug Type
Small Molecule
Chemical Formula
C10H13NO3
CAS Number
658-48-0
Unique Ingredient Identifier
X88TTO174Z

Overview

Racemetyrosine is under investigation in clinical trial NCT03512756 (A Randomized Phase 2/3 Multi-center Study of SM-88 in Patients With Metastatic Pancreatic Cancer).

Background

Racemetyrosine is under investigation in clinical trial NCT03512756 (A Randomized Phase 2/3 Multi-center Study of SM-88 in Patients With Metastatic Pancreatic Cancer).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Withdrawn
Posted: 2015/09/29
Sponsor:
Tyme, Inc

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath